These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8778594)

  • 1. Treatment of rheumatoid arthritis.
    Schinagl EF; Strauss PC
    N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778594
    [No Abstract]   [Full Text] [Related]  

  • 2. History of enteric coated sulfasalazine in rheumatoid arthritis.
    Pinals RS
    J Rheumatol Suppl; 1988 Sep; 16():1-4. PubMed ID: 2903922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on enteric-coated sulphasalazine in rheumatoid arthritis. Proceedings of a symposium. London, December 6, 1985.
    Drugs; 1986; 32 Suppl 1():1-80. PubMed ID: 2877848
    [No Abstract]   [Full Text] [Related]  

  • 4. [A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis].
    Kawai S; Ochi T; Kondo H; Nishioka K; Nobuyuki N; Yoshino S
    Ryumachi; 2002 Feb; 42(1):76-9. PubMed ID: 11925910
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    van Rijthoven AW
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):539. PubMed ID: 10735141
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and treatment of early rheumatoid arthritis].
    Jacobsen S; Skjødt H; Hørslev-Petersen K; Hansen TM; Sørensen SF; Petersen J; Junker P; Stengaard-Pedersen K
    Ugeskr Laeger; 2002 Feb; 164(8):1060-1. PubMed ID: 11894713
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A double blind comparative study between salazosulfapyridine enteric coated tablets (PJ-306) and lobenzarit disodium (CCA) in rheumatoid arthritis].
    Nishioka K; Azuma T; Iwasaki Y
    Ryumachi; 1991 Jun; 31(3):346-67. PubMed ID: 1683016
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 11. Low dose prednisolone for treatment of RA.
    Kirwan J; Boers M
    Ann Rheum Dis; 2004 Nov; 63(11):1533-4; author reply 1534. PubMed ID: 15479919
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheumatoid arthritis: not yet curable with early intensive therapy.
    Emery P
    Lancet; 1997 Aug; 350(9074):304-5. PubMed ID: 9251629
    [No Abstract]   [Full Text] [Related]  

  • 13. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulphasalazine and inflammatory bowel disease.
    Chapman P
    N Z Med J; 1987 Apr; 100(822):257. PubMed ID: 2901061
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy in rheumatoid arthritis].
    Johnsen V; Førre Ø; Haga HJ; Kvien TK; Mikkelsen K; Nordvåg BY; Rødevand E
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1511-3. PubMed ID: 12822010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.